PRACTICE ALERT PODCAST
Audio

USPSTF weighs in on postmenopausal hormone therapy to prevent chronic conditions

J Fam Pract. 2018 February;67(2):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

The US Preventive Services Task Force recommends against the use of estrogen, alone or combined with progestin, to prevent chronic conditions in asymptomatic postmenopausal women. Here’s why.

 

Resources

US Preventive Services Task Force. Final Recommendation Statement: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/menopausal-hormone-therapy-preventive-medication1. Accessed January 5, 2018.

Recommended Reading

STUDY: More mammograms after cost-sharing elimination
MDedge Family Medicine
Cesarean delivery reduces some risks, raises others
MDedge Family Medicine
New hematologic, cardiovascular system link may have therapeutic implications
MDedge Family Medicine
Greater gynecological but not medical risks with hysteroscopic sterilization
MDedge Family Medicine
Women filling more ADHD prescriptions
MDedge Family Medicine
Sleep improved with urinary incontinence treatment
MDedge Family Medicine
Trial seeks improved regimens for pregnant women with HIV
MDedge Family Medicine
Adacel Tdap effective throughout third trimester vaccination window
MDedge Family Medicine
Senate votes on 20-week abortion ban
MDedge Family Medicine
Children’s behavioral problems tied to mothers’ postpartum depression
MDedge Family Medicine